This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Analyst Blog: Archive
Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?
by Ahan Chakraborty
Let's look at five big pharma companies, GILD, BMY, MRK, ABBV and SNY slated to release their first-quarter 2025 results this week.
SNYPositive Net Change BMYNegative Net Change MRKNegative Net Change GILDPositive Net Change ABBVPositive Net Change
biotechnology biotechs medical pharmaceuticals
Can These 4 Energy Stocks Beat Wall Street's Q4 Estimates?
by Turjya Saha
Here is a look at what to expect from energy stocks APA, OVV, VIST, and EXE ahead of their quarterly earnings reports, set to be released tomorrow.
APAPositive Net Change VISTPositive Net Change OVVPositive Net Change EXENo Net Change
energy oil-energy
Leisure Stocks to Report Q4 Earnings on Feb. 25: PLNT, CWH, AMC & CZR
by Harendra Ray
Optimizing business processes, consistent partnerships and digital initiatives are likely to have aided Leisure stocks like PLNT, CWH, AMC and CZR in Q4.
CWHNegative Net Change CZRNegative Net Change AMCNegative Net Change PLNTNegative Net Change
consumer-discretionary earnings
What's in Store for These 5 Biotech Stocks This Earnings Season?
by Ahan Chakraborty
Let's look at five biotech and drug companies, VTRS, PRGO, NVAX, NTLA and IOVA, slated to release their fourth-quarter 2024 results on Feb. 27, 2025.
PRGONegative Net Change NVAXNegative Net Change NTLANegative Net Change IOVANegative Net Change VTRSNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals vaccines
What to Expect From These 4 Medical Device Stocks in Q4 Earnings?
by Indrajit Bandyopadhyay
Here is a sneak peek into how four Medical Device stocks, namely FMS, MASI, MMSI and INGN, are expected to fare in their quarterly results, slated to be released tomorrow.
MASINegative Net Change FMSNegative Net Change MMSINegative Net Change INGNNegative Net Change
medical medical-devices
Are These 5 Beverage Stocks Poised for Earnings Beat This Season?
by Zacks Equity Research
The beverage industry players are expected to have gained from expansion, pricing and solid demand, but inflation and currency woes are likely to have posed challenges.
FMXPositive Net Change BUDPositive Net Change MNSTPositive Net Change SAMNegative Net Change KDPPositive Net Change
consumer-staples
What's in Store for These Three Restaurant Stocks in Q4 Earnings?
by Mrithunjoy Kaushik
Restaurant stocks are likely to have benefited from marketing initiatives, service digitization, new store openings and menu offerings in the fourth quarter of 2024.
BJRINegative Net Change TXRHNegative Net Change SHAKNegative Net Change
earnings restaurants retail
What to Expect From These 3 MedTech Stocks This Earnings Season?
by Indrajit Bandyopadhyay
Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, slated to be released tomorrow.
AMNPositive Net Change GKOSNegative Net Change ITGRPositive Net Change
medical medical-devices
Will These 4 Energy Stocks Surpass Q4 Earnings Forecasts?
by Turjya Saha
Investors interested in Energy stocks can keep an eye on the fourth-quarter 2024 earnings reports of OII, PUMP, E and NOG.
EPositive Net Change OIIPositive Net Change NOGPositive Net Change PUMPNegative Net Change
energy oil-energy
Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?
by Ahan Chakraborty
Let's look at five biotech and drug companies, AXSM, HALO, FOLD, BMRN and INSM, slated to release their fourth-quarter 2024 results this week.
BMRNNegative Net Change HALONegative Net Change FOLDNo Net Change INSMNegative Net Change AXSMNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals